The prognostic significance of specific HOX gene expression patterns in ovarian cancer

Kelley, Zoe, Moller-Levet, Carla, McGrath, Sophie, Butler-Manuel, Simon, Madhuri, Thumuluru, Kierzek, Andrzej, Morgan, Richard ORCID:, Pandha, Hardev and Michael, Agnieszka (2016) The prognostic significance of specific HOX gene expression patterns in ovarian cancer. International journal of cancer, 139 (7). pp. 1608-1617. ISSN 0020-7136

[thumbnail of The_prognostic_significance_of_specific_HOX_gene_expression_patterns_in_ovarian_cancer.pdf]
The_prognostic_significance_of_specific_HOX_gene_expression_patterns_in_ovarian_cancer.pdf - Published Version
Available under License Creative Commons Attribution.

Download (700kB) | Preview


HOX genes are vital for all aspects of mammalian growth and differentiation, and their dysregulated expression is related to ovarian carcinogenesis. The aim of the current study was to establish the prognostic value of HOX ysregulation as well as its role in platinum resistance. The potential to target HOX proteins through the HOX/PBX interaction was also explored in the context of platinum resistance. HOX gene expression was determined in ovarian cancer cell lines and primary EOCs by QPCR, and compared to expression in normal ovarian epithelium and fallopian tube tissue samples. Statistical analysis included one-way ANOVA and t-tests, using statistical software R and GraphPad. The analysis identified 36 of the 39 HOX genes as being overexpressed in high grade serous EOC compared to normal tissue. We detected a molecular HOX gene-signature that predicted poor outcome. Overexpression of HOXB4 and HOXB9 was identified in high grade serous cell lines after platinum resistance developed. Targeting the HOX/PBX dimer with the HXR9 peptide enhanced the cytotoxicity of cisplatin in platinum-resistant ovarian
cancer. In conclusion, this study has shown the HOX genes are highly dysregulated in ovarian cancer with high expression of HOXA13, B6, C13, D1 and D13 being predictive of poor clinical outcome. Targeting the HOX/PBX dimer in platinum–resistant cancer represents a potentially new therapeutic option that should be further developed and tested in clinical trials

Item Type: Article
Identifier: 10.1002/ijc.30204
Keywords: ovarian cancer, HOX genes, survival, prognosis, targeted treatment
Subjects: Natural sciences > Cell and molecular biology
Related URLs:
Depositing User: Richard Morgan
Date Deposited: 08 Jul 2020 14:06
Last Modified: 06 Feb 2024 16:03


Downloads per month over past year

Actions (login required)

View Item View Item